Goldman Sachs Group set a €48.00 ($56.47) target price on Fresenius SE & Co. KGaA (FRE.F) (FRA:FRE) in a research note issued to investors on Friday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
A number of other research analysts have also commented on FRE. Independent Research set a €52.00 ($61.18) price objective on shares of Fresenius SE & Co. KGaA (FRE.F) and gave the company a buy rating in a research note on Friday, July 31st. DZ Bank reissued a buy rating on shares of Fresenius SE & Co. KGaA (FRE.F) in a report on Wednesday, October 14th. Deutsche Bank Aktiengesellschaft set a €57.00 ($67.06) price target on Fresenius SE & Co. KGaA (FRE.F) and gave the company a buy rating in a research note on Friday, July 31st. Berenberg Bank set a €59.50 ($70.00) price objective on Fresenius SE & Co. KGaA (FRE.F) and gave the stock a buy rating in a research report on Wednesday, October 21st. Finally, Sanford C. Bernstein set a €47.00 ($55.29) price target on shares of Fresenius SE & Co. KGaA (FRE.F) and gave the stock a buy rating in a research note on Thursday, July 30th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and eleven have given a buy rating to the company’s stock. The stock presently has a consensus rating of Buy and an average price target of €51.46 ($60.54).
FRE opened at €33.86 ($39.84) on Friday. Fresenius SE & Co. KGaA has a one year low of €60.16 ($70.78) and a one year high of €80.00 ($94.12). The business’s 50-day simple moving average is €37.90 and its 200-day simple moving average is €40.55.
Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Featured Article: What is a stock portfolio tracker?
Receive News & Ratings for Fresenius SE & Co. KGaA (FRE.F) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA (FRE.F) and related companies with MarketBeat.com's FREE daily email newsletter.